loading

Eledon Pharmaceuticals Inc Stock (ELDN) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
5.14%
10.87
10.34 11.20 10.35 11.11
Operating Income/Loss
5.14%
-10.87
-10.34 -11.20 -10.35 -11.11
Income/Loss From Continuing Operations Before Tax
6.95%
-10.29
-9.626 -10.35 -9.579 -10.77
Income/Loss From Continuing Operations After Tax
6.95%
-10.29
-9.626 -10.35 -9.579 -10.77
Net Income/Loss
6.95%
-10.29
-9.626 -10.35 -9.579 -10.77
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1,560%
29.99
1.8061 29.97 24.01 14.29
Diluted Average Shares
1,560%
29.99
1.8061 29.97 24.01 14.29
Basic Earnings Per Share
17.24%
-0.34
-0.29 -0.35 -0.40 -0.75
Diluted Earnings Per Share
17.24%
-0.34
-0.29 -0.35 -0.40 -0.75
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$80.78
price down icon 0.82%
$20.67
price down icon 0.53%
$353.75
price down icon 0.12%
$5.04
price down icon 2.14%
biotechnology ONC
$228.87
price up icon 0.53%
$119.94
price down icon 1.99%
Cap:     |  Volume (24h):